Skip to main content

Table 1 Patient characteristics

From: Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation

Parameters
N (male/female) 100 (61/39)
Age (years) 69.3 ± 9.6
Type of AF
 Paroxysmal [n (%)] 68 (68%)
 Persistent [n (%)] 20 (20%)
 Long-lasting [n (%)] 12 (12%)
 Duration of AF (months) 11.7 ± 17.9
 Hypertension [n (%)] 49 (49%)
 Diabetes [n (%)] 14 (14%)
 Structural heart disease [n (%)] 11 (11%)
 CHADS2 1.2 ± 1.0
 CHA2DS2-VASc 2.3 ± 1.3
 LVEF (%) 64.3 ± 7.8
 LAD (mm) 36.4 ± 7.3
 Ccr (mL/min) 62.0 ± 17.8
 BNP (pg/mL) 129.5 ± 191.4
  1. AF atrial fibrillation, LVEF left ventricular ejection fraction, LAD left atrium diameter, BNP brain natriuretic peptide